SCHEMBL6854491

SCHEMBL6854491

CCCCCCCCCCc1cnc(-c2ccc(OCCCCCCCC[Si](C)(C)C[Si](C)(C)C)cc2)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 4/20 0.51
RAB9A P51151 6/20 0.50
KDM4E B2RXH2 5/20 0.50
NPC1 O15118 4/20 0.50
SMN1; SMN2 Q16637 4/20 0.50
HSD17B10 Q99714 2/20 0.50
ALDH1A1 P00352 5/20 0.48
MAPT P10636 3/20 0.48
HPGD P15428 3/20 0.48
MEN1 O00255 2/20 0.48
USP2 O75604 2/20 0.48
KMT2A Q03164 2/20 0.48
GAA P10253 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.45
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
HTT P42858 1/20 0.41
CYP3A4 P08684 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6858725 1.00 RARB (0.51) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL6017416 1.00 RARB (0.51) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL8973361 1.00 RARB (0.51) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL9331013 0.92 RARB (0.54) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL9330847 0.92 RARB (0.54) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL6855968 0.91 RARB (0.51) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL6017512 0.91 RAB9A (0.54) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL6858712 0.91 RARB (0.51) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL9334359 0.91 RARB (0.53) RARBRAB9AKDM4ENPC1SMN1; SMN2
SCHEMBL9331279 0.91 RARB (0.53) RARBRAB9AKDM4ENPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6783812-B2 USEFUL IN THE MANUFACTURE OF OPTICAL DEVICES; STABILITY DISPLAYTECH, INC. 2004-08-31 US disclosed
US-20020130299-A1 Alkyl silane liquid crystal compounds CITIZEN FINEDEVICE CO., LTD. (JP) 2002-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020130299-A1 Alkyl silane liquid crystal compounds SMURF1, SMURF2, DSTN RARB 4255/4885RAB9A 3181/4885KDM4E 651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.